Semtech shares up after earnings report
Banking & Finance, Earnings, Latest news, Regions, Technology, Tri-County Public Companies, Ventura CountyCamarillo-based Semtech Corp. delivered a strong fourth quarter and full year fiscal 2021 earnings report after the markets closed March 16, recording an all-time best revenue mark along with a bump in net profit for the full year. Semtech, a semiconductor company specializing in Internet of Things applications, had revenue of $740.9 million for the Read More →
Street Smarts: 2022 shaping up as a change year in Ventura County politics
Columns, Latest newsIt looks like there is going to be significant turnover in Ventura County politics this year. Clerk-Recorder Mark Lunn, Treasurer and Tax Collector Steven Hintz and Assessor Dan Goodwin have all decided not to run for re-election. These are all county veterans, with Lunn and Hints having served three terms and Goodwin finishing his sixth. Read More →
Portfolio Watch: Energy market upended by war in Ukraine
Banking & Finance, Latest news, Personal Finance, Subscriber contentThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Street Smarts: State rolls out grant program for smallest businesses affected by pandemic
Columns, Latest news, Law & Goverment, NonprofitsMicrobusiness grants are becoming available for companies with less than $50,000 in revenue that have been impacted by COVID-19. Under a program set to launch March 7, Santa Barbara County is partnering with the Santa Barbara Foundation to launch its program for north and south county businesses. The grants do not have to be repaid. Read More →

Atara reports patient death in cancer treatment study
Banking & Finance, Health Care & Life Science, Latest news, Tri-County Public CompaniesAtara Biotherapeutics, a South San Francisco-based drug development company with major operations in Thousand Oaks, reported to the U.S. Food and Drug Administration on Feb. 18 that a patient died in one of its Phase 1 trials. The patient, who was being treated at a Memorial Sloan Kettering Cancer Center location in New York, suffered Read More →